NIH-funded research U01 cooperative agreement

Preventing anal cancer in men who have sex with men living with HIV

Official title: Integrated Model for the Prevention of Anal Cancer using screen and Treat for HSIL (IMPACT)

Funded at University of Maryland Baltimore · NIH-10907554 · Data updated 2026-11-12

This study is looking to help men who have sex with men and are living with HIV by offering a program to screen and treat early signs of anal cancer, making it easier for them to get the care they need in Nigeria and the U.S.

More Anal Cancer research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Maryland Baltimore
NIH-funded
Lab location1 site (Baltimore, United States)
Project startSeptember 15, 2022
Project endAugust 31, 2027
Funding year2024
Award (this year)$727,189
NIH project number5U01CA275053-03
Project IDNIH-10907554 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are men who have sex with men and are living with HIV, particularly those in low- and middle-income countries.

Less likely to help

Patients who do not identify as men who have sex with men or who are not living with HIV may not benefit from this research.

What this research studies

This research focuses on preventing anal cancer among men who have sex with men (MSM) living with HIV by implementing a screening and treatment program for high-grade squamous intraepithelial lesions (HSIL). The study will take place at the TRUST clinic in Nigeria, leveraging existing HIV care infrastructure to enhance access to anal cancer prevention interventions. By addressing knowledge gaps and barriers to treatment, the project aims to increase the uptake of HSIL screening and treatment in this high-risk population. Participants will be involved in a randomized controlled trial across multiple clinical sites in the United States and Nigeria.

Why it matters

Potential benefit: If successful, this research could significantly reduce the incidence of anal cancer in a vulnerable population.

How similar studies have gone: Previous studies have shown success in implementing HSIL screening and treatment in similar populations, indicating a promising approach.

Where this research is happening

  • University of Maryland Baltimore
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Nowak, Rebecca G. — University of Maryland Baltimore
  • Study coordinator: Nowak, Rebecca G.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.